Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 245 clinical trials
None

  • None views
None

  • None views
None

  • None views
None

  • None views
Preliminary Antitumor Activity Safety and Tolerability of Tislelizumab in Combination With Lenvatinib for Hepatocellular Carcinoma

The primary objective of this study is to assess the preliminary antitumor activity as indicated by overall response rate (ORR) of tislelizumab in combination with lenvatinib in participants with unresectable locally advanced or metastatic hepatocellular carcinoma (HCC).

unresectable hepatocellular carcinoma
metastatic hepatocellular carcinoma
hepatocellular carcinoma metastatic
lenvatinib
hepatocellular carcinoma
  • 0 views
  • 19 Feb, 2024